An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
Saturday, September 30 1:22 – 1:42 p.m. Non Definitive Lung Options: Palliation and XRT Alone Location: Room 33 Uzoma Iheagwara, MD, PhD – UPMC Hillman Cancer Center Sunday, October 1 8 – 9 a.m. SS 02 – GYN 1: Integrating…
Published in Science Immunology, researchers led by Dario Vignali, PhD, distinguished professor and chair of the Department of Immunology and member of UPMC Hillman Cancer Center, identified a genetic mechanism to enhance an immune system’s antitumor activity. By finding a…
Abby Overacre-Delgoffe, PhD, assistant professor in the Pitt School of Medicine’s Department of Immunology and UPMC Hillman Cancer Center, has received a National Institute of Allergy and Infectious Diseases (NIAID) New Innovator Award for her project, “Microbiota initiation of lymphangiogenesis.” Totaling…
UPMC Hillman Cancer Center would like to welcome Melanie Potiaumpai, PhD, MPH, effective August 1, 2023. Dr. Potiaumpai is joining as assistant professor in the Department of Medicine, Division of Hematology/Oncology at the University of Pittsburgh and a member of…
UPMC Hillman Cancer Center would like to welcome Anthony (Tony) R. Cillo, PhD, effective August 1, 2023. Dr. Cillo is an assistant professor in the Department of Immunology at the University of Pittsburgh and a member of the Tumor Microenvironment…
Saiful Huq, PhD, FAAPM, FInstP, Director of the Medical Physics Division at UPMC Hillman Cancer Center and Professor of Radiation Oncology at the University of Pittsburgh School of Medicine, received the William D. Coolidge Gold Medal Award from the American…
Benjamin A. Nacev, MD, PhD, assistant professor of medicine in the Division of Hematology/Oncology, has been named a Damon Runyon Clinical Investigator by the Damon Runyon Cancer Research Foundation. With his mentor, Jeremy Rich, MD, Dr. Nacev will receive $600,000…
UPMC Hillman Cancer Center is pleased to welcome Yvonne Mowery, MD, PhD, DABR, effective June 1, 2023. Dr. Mowery is associate professor in the Department of Radiation Oncology at the University of Pittsburgh and will see patients in the outpatient clinic…
Friday, June 2 Posters Divya Natesan “Differences in real-world pembrolizumab dosing patterns (every 3 weeks versus every 6 weeks) across a large cancer center network” 8 to 11 a.m. Hall A | Abstract 2592 | Board 434 Jingxiao Jin, MD…
Researchers have known that microorganisms in the gut can impact the effectiveness of immunogenic chemotherapies for cancer patients. When studies showed that the same could be true for immune checkpoint inhibitors, it opened the possibility for better treatment options for…
